Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation.
Amides
/ chemistry
Carcinoma, Squamous Cell
/ drug therapy
Cell Line, Tumor
Cell Proliferation
Cullin Proteins
/ chemistry
Cyclopentanes
/ pharmacology
Drug Design
Fibroblasts
/ metabolism
Glycine
/ chemistry
Humans
Intracellular Signaling Peptides and Proteins
/ antagonists & inhibitors
NEDD8 Protein
/ chemistry
Protein Domains
Protein Interaction Mapping
Pyrazoles
/ chemistry
Pyridones
/ chemistry
Pyrimidines
/ pharmacology
Reactive Oxygen Species
/ chemistry
Structure-Activity Relationship
Ubiquitin-Conjugating Enzymes
/ chemistry
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
26 09 2019
26 09 2019
Historique:
pubmed:
30
8
2019
medline:
23
6
2020
entrez:
30
8
2019
Statut:
ppublish
Résumé
Chemical control of cullin neddylation is attracting increased attention based largely on the successes of the NEDD8-activating enzyme (E1) inhibitor pevonedistat. Recently reported chemical probes enable selective and time-dependent inhibition of downstream members of the neddylation trienzymatic cascade including the co-E3, DCN1. In this work, we report the optimization of a novel class of small molecule inhibitors of the DCN1-UBE2M interaction. Rational X-ray co-structure enabled optimization afforded a 25-fold improvement in potency relative to the initial screening hit. The potency gains are largely attributed to additional hydrophobic interactions mimicking the N-terminal acetyl group that drives binding of UBE2M to DCN1. The compounds inhibit the protein-protein interaction, block NEDD8 transfer in biochemical assays, engage DCN1 in cells, and selectively reduce the steady-state neddylation of Cul1 and Cul3 in two squamous carcinoma cell lines harboring DCN1 amplification.
Identifiants
pubmed: 31465221
doi: 10.1021/acs.jmedchem.9b00410
pmc: PMC7228038
mid: NIHMS1586503
doi:
Substances chimiques
Amides
0
CUL3 protein, human
0
Cullin 1
0
Cullin Proteins
0
Cyclopentanes
0
DCUN1D1 protein, human
0
Intracellular Signaling Peptides and Proteins
0
NEDD8 Protein
0
NEDD8 protein, human
0
Pyrazoles
0
Pyridones
0
Pyrimidines
0
Reactive Oxygen Species
0
Ubiquitin-Conjugating Enzymes
EC 2.3.2.23
UBE2M protein, human
EC 6.3.2.-
pevonedistat
S3AZD8D215
Glycine
TE7660XO1C
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
8429-8442Subventions
Organisme : NCI NIH HHS
ID : R01 CA247365
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA021765
Pays : United States
Organisme : NIGMS NIH HHS
ID : F32 GM113310
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIGMS NIH HHS
ID : R37 GM069530
Pays : United States
Références
Clin Cancer Res. 2003 Jun;9(6):2300-6
pubmed: 12796399
J Med Chem. 2019 Mar 14;62(5):2772-2797
pubmed: 30803229
Cell Res. 2016 Apr;26(4):484-98
pubmed: 27002218
Cell Div. 2016 Jun 10;11:8
pubmed: 27293474
Nat Commun. 2016 Oct 24;7:13166
pubmed: 27774986
Drug Discov Today. 2009 Nov;14(21-22):1011-20
pubmed: 19729075
Cancer Chemother Pharmacol. 2018 May;81(5):797-808
pubmed: 29450620
J Cell Sci. 2016 Apr 1;129(7):1441-54
pubmed: 26906416
Ann Surg Oncol. 2004 May;11(5):530-4
pubmed: 15123463
J Biol Chem. 2008 Nov 28;283(48):33211-20
pubmed: 18826954
Nat Chem Biol. 2017 Aug;13(8):850-857
pubmed: 28581483
Eur Rev Med Pharmacol Sci. 2017 Oct;21(19):4283-4291
pubmed: 29077169
Org Lett. 2016 Feb 19;18(4):696-9
pubmed: 26859161
J Med Chem. 2018 Mar 8;61(5):1934-1950
pubmed: 29438612
Clin Cancer Res. 2013 Oct 15;19(20):5549-51
pubmed: 24004673
J Med Chem. 2018 Apr 12;61(7):2694-2706
pubmed: 29547693
PLoS One. 2014 May 29;9(5):e98293
pubmed: 24874471
Science. 2011 Nov 4;334(6056):674-8
pubmed: 21940857
J Biol Chem. 2016 Mar 18;291(12):6200-17
pubmed: 26792857
Dev Biol. 2018 Jan 15;433(2):210-217
pubmed: 29291974
Exp Ther Med. 2018 Aug;16(2):1000-1008
pubmed: 30116351
Cancer Res. 2006 Oct 1;66(19):9437-44
pubmed: 17018598
Medicina (Kaunas). 2015;51(1):1-9
pubmed: 25744769
Cell Signal. 2018 Apr;44:92-102
pubmed: 29331584
Trends Biochem Sci. 2018 Feb;43(2):95-107
pubmed: 29249570
Cell. 2014 Jun 19;157(7):1671-84
pubmed: 24949976
Science. 2013 Jul 5;341(6141):84-7
pubmed: 23828940
Curr Opin Struct Biol. 2011 Apr;21(2):257-64
pubmed: 21288713
Nat Commun. 2017 Oct 27;8(1):1150
pubmed: 29074978
Nature. 2005 Jun 30;435(7046):1257-61
pubmed: 15988528
Ann Thorac Surg. 2004 Nov;78(5):1734-41
pubmed: 15511464
Clin Cancer Res. 2008 Nov 1;14(21):6780-9
pubmed: 18980971
Curr Opin Struct Biol. 2010 Dec;20(6):714-21
pubmed: 20880695
Trends Cell Biol. 2014 Jul;24(7):389-99
pubmed: 24630736
J Clin Invest. 2014 Jan;124(1):6-12
pubmed: 24382383
Biochem J. 2015 May 1;467(3):365-86
pubmed: 25886174
Annu Rev Biochem. 2017 Jun 20;86:129-157
pubmed: 28375744
J Med Chem. 2018 Apr 12;61(7):2680-2693
pubmed: 29547696
Structure. 2013 Jan 8;21(1):42-53
pubmed: 23201271
Mol Cell. 2013 May 23;50(4):540-51
pubmed: 23603116
Nat Rev Mol Cell Biol. 2005 Jan;6(1):9-20
pubmed: 15688063